Lilly Icos reports Cialis Phase III data

Lilly Icos, a joint venture between Icos (ICOS) and Eli Lilly (LLY), said data from a 196-patient Phase III study showed 85% of men given 20 mg Cialis had significantly improved erections, 78% of inte...